Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burger

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Antimicrobial Agents|August 13, 2016
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepineE J Smolders, C T M M de Kanter, N van 't Veer, et al.
British Journal of Cancer|February 16, 2013
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsR W F van Leeuwen, D H S Brundel, C Neef, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2014
Five year results of an international proficiency testing programme for measurement of antifungal drug concentrationsV J C Lempers, J W C Alffenaar, D J Touw, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteersR E Aarnoutse, J A H Droste, J J G van Oosterhout, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2007
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practiceR M M Cleijsen, M E van de Ende, F P Kroon, et al.
HIV Medicine|December 2, 2017
Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfectE J Smolders, C Smit, Ctmm de Kanter, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteersJ A H Droste, C P W G M Verweij-van Wissen, B P Kearney, et al.
Antiviral Therapy|February 22, 2000
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapyD M Burger, R M Hoetelmans, P W Hugen, et al.
International Journal of Antimicrobial Agents|December 5, 2022
Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)H A B Prins, L Zino, E M Svensson, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Antimicrobial Agents|August 13, 2016
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepineE J Smolders, C T M M de Kanter, N van 't Veer, et al.
British Journal of Cancer|February 16, 2013
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsR W F van Leeuwen, D H S Brundel, C Neef, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2014
Five year results of an international proficiency testing programme for measurement of antifungal drug concentrationsV J C Lempers, J W C Alffenaar, D J Touw, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteersR E Aarnoutse, J A H Droste, J J G van Oosterhout, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2007
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practiceR M M Cleijsen, M E van de Ende, F P Kroon, et al.
HIV Medicine|December 2, 2017
Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfectE J Smolders, C Smit, Ctmm de Kanter, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteersJ A H Droste, C P W G M Verweij-van Wissen, B P Kearney, et al.
Antiviral Therapy|February 22, 2000
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapyD M Burger, R M Hoetelmans, P W Hugen, et al.
International Journal of Antimicrobial Agents|December 5, 2022
Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)H A B Prins, L Zino, E M Svensson, et al.
Pageof 14